/Companies

Protalix

NYSE: PLX

Karmiel, IL · 2 known investors

Find your way into Protalix

Sign up to see every warm intro you have to Protalix

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Protalix team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Protalix is a biopharmaceutical company that develops and manufactures innovative pharmaceutical products, including treatments for orphan and rare diseases. The company leverages its proprietary technology platform and extensive expertise in drug development, regulatory affairs, and pharmaceutical manufacturing.

Founders & leadership

MB
Moshe BashanPresident and Chief Executive Officer
DBDror Bashan
Dror BashanPresident and Chief Executive Officer, DirectorDror Bashan is President and CEO of Protalix, a biopharmaceutical company developing treatments for rare and orphan diseases using proprietary plant cell-based technology. He has over 20 years of experience in pharmaceutical and biotechnology sectors, including prior roles at Teva, with expertise in business development, finance, and drug regulatory approval processes.

Investors · 2

Frequently asked questions

What does Protalix do?
Protalix is a biopharmaceutical company that develops and manufactures innovative pharmaceutical products, including treatments for orphan and rare diseases. The company leverages its proprietary technology platform and extensive expertise in drug development, regulatory affairs, and pharmaceutical manufacturing.
Who are Protalix's investors?
Protalix's investors include Pontifax Venture Capital, Sofinnova Ventures.
Where is Protalix headquartered?
Protalix is headquartered in Karmiel, IL.